Small Cell Lung Cancer remains among oncology's most formidable adversaries, characterized by extraordinary aggressiveness and limited long-term treatment success. Although patients demonstrate initial favorable responses to standard chemotherapy and radiation regimens, therapeutic failure occurs almost inevitably, producing survival outcomes significantly inferior to other lung malignancy...